Pershing Square Capital Management

Pershing Square Capital Management founder Bill Ackman had a conversation with computer scientist and tech YouTuber Lex Fridman earlier this week, during which he divulged his process to identify the right companies for long-term, high-value investment.  What Happened: During the interview,...

Dan Loeb and Bill Ackman are billionaire activist investors who own hedge funds Third Point Management and Pershing Square Capital Management, respectively. Both have been outspoken in the media this year, as Loeb wanted Disney to sell its unprofitable ESPN segment. After that, Loeb directed his...

Hedge fund investor and Pershing Square Capital Management CEO Bill Ackman has a word of advice for the U.S. Federal Reserve, which is due to announce its interest rate decision on Wednesday after a two-day meeting of its monetary policy arm. Ackman's Call: ...

Bill Ackman’s Pershing Square Capital Management exited its position in Netflix (NASDAQ: NFLX) on Wednesday, the billionaire hedge fund manager told shareholders in a letter. The Loss: Pershing Square built the Netflix stake three months ago, buying 3.1...

Volatility in global financial markets triggered by the conflict in Ukraine has investors concerned about a potential U.S. recession in 2022. The SPDR S&P 500 ETF Trust (NYSE: SPY) is down more than 10% year-to-date, while WTI crude oil prices have risen to 13-year highs. In volatile times like...

Every day, Benzinga TV covers the biggest topics of the stock market. Benzinga’s new weekly highlights show features the top ten events of the previous week. Follow Benzinga on YouTube for daily shows committed to providing the best market news and commentary.  Here are the top ten stock...

Tennis, intermittent fasting and a good night’s sleep keep Bill Ackman at his prime. “I work out pretty intensely,” the activist investor told Shane Parrish on The Knowledge Project. “I play tennis, which, in addition to a workout, it’s almost a form of meditation for...

Billionaire activist investor Bill Ackman made his activist case against Automatic Data Processing (NASDAQ: ADP) public last week, which was well researched and "reflected significant efforts at due diligence," analysts at Baird Equity Research commented in a research report. Ackman and his team...

Bill Ackman has been criticized as “foolish, inappropriate [and] irresponsible” for his 8-percent stake in and board nominations for Automatic Data Processing (NASDAQ: ADP). Some doubt Pershing Square Capital Management’s capacity to achieve its expressed goals of “...

Restaurant Brands International Inc (NYSE: QSR) fell more than 1 percent Wednesday on news that Pershing Square Capital Management divested a 10 million share block. But the sale wasn't reflective of any negative sentiment toward the company. It was “simply for portfolio management...

Last week, Pershing Square CEO Bill Ackman told Bloomberg he would likely shy away from pharmaceutical companies following his $4 billion loss in Valeant Pharmaceuticals Intl Inc (NYSE: VRX). Perhaps Ackman meant it for investments, but not for research. His firm is still working to advance the...

Trian Fund Management LP took a $3.5 billion stake in Procter & Gamble Co (NYSE: PG) Tuesday night and pushed shares to a two-year peak above $91.5. It’s the largest position the activist investor has ever taken in a company, and it’s the second time in five years that P&G has...

Pershing Square Capital Management, a major investment holding company managed by billionaire Bill Ackman, released on Wednesday its quarterly letter to investors. Net of all fees, the fund returned 2.9 percent in the third quarter and is lower by 13.5 percent since the start of 2016. By comparison...

Billionaire investor Bill Ackman acquired an approximate 8.5 percent stake in Zoetis Inc (NYSE: ZTS), a producer of animal medicines and vaccinations, back in November 2014. Ackman and his hedge fund Pershing Square Capital Management first bought 5.5 million shares of Zoetis in 2014 at $34 per...

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has been in the news a lot lately. Among the potentially unsavory news is the surprise return of CEO Mike Pearson after an extended sick leave, a canceled conference call followed by one-on-one calls to certain bullish analysts, which then raised...